As runners, joggers, and walkers hit the streets and trails to burn calories and enjoy the warm weather, HundredX turns to "The Crowd" to get the latest on sneaker trends.


Among high inflation for everyday expenses, sneaker-wearers are keeping lower-cost brands in mind. Looking at 250,000 pieces of customer feedback across the fashion, apparel, and footwear sector, we find that Purchase Intent1,2 has been flat for the overall sportswear industry, but athletic footwear has seen some movement.


Reebok and Puma, two sneaker brands known for their relative affordability, jumped in Purchase Intent over the past three months as they continue to please customers with their prices. Meanwhile, Nike has slumped as customers feel unhappier with the brand's price, quality, comfort, and image.


A close analysis of our data reveals:

Key Takeaways:

  • Over the past three months, sportswear demand outlook remained steady; it grew for luxury goods, healthcare apparel, and jewelry

  • Nike Purchase Intent fell 4% over the past three months, even as it jumped for Reebok (+4%) and PUMA (+2%).


  • Nike Purchase Intent fell the most people making more than $50,000 per year and middle-aged adults and was most resilient for young adults and people making less than $50,000 per year.


  • In recent months, Nike customers have felt unhappier about the company’s prices, quality, comfort, and brand image. 


  • In contrast, customer sentiment3 toward the above factors surged for Reebok, which released a number of new shoes in early 2023. Price, Comfort, and Quality are the three most selected reasons why someone likes or dislikes a sportswear brand.


Discover HundredX insights into Sportswear and Athletic Footwear:

  • Slide title

    Write your caption here
    Button
  • Slide title

    Sportswear demand outlook is steady. Healthcare apparel has seen the largest pickup (+2%) over the last three months, along with luxury goods (+1%) and jewelry (+2%). ​

    • Note: We classify sportswear as the average of the following brands: Adidas, Aerie, Asics, Athleta, Champion, Champs Sports, Columbia, Fabletics, Lululemon, New Balance, Nike, Nike Store, PUMA, Reebok, REI (Apparel), The North Face, Under Armour, and Vuori.​
    Button
  • Slide title

    Nike Purchase Intent dipped by 4% over the past three months. Over the same period, many of Nike’s largest competitors, especially Reebok (+4%) and PUMA (+2%) gained Purchase Intent.

    Button
  • Slide title

    Nike’s Purchase Intent has fallen more for customers making $50K+/yr the last three months (4%) than those making <$50K (2%) the last three months. The sportswear industry was flat for both. Lower-income customers are often also the younger ones, which have been more resilient.

    Button
  • Slide title

    Nike’s Purchase Intent has been down over the last three months for all age groups, but it has been most resilient for 18-39 (-2%) and most for 40-59 (-5%). Nike has been down more than the broader industry for all age groups.

    Button
  • Slide title

    Customers grew much happier with prices for PUMA (+10%) and Reebok (+8%) since January. Nike was up, but less (+3%), while others were largely flat. There has been a lot of focus on pricing and margins. This may indicate PUMA continues to use pricing to support market share. 

    Button
  • Slide title

    Reebok also surged in customer sentiment toward Comfort the last three months(+8%). During that period, it stayed stable for the overall sportswear industry but fell 2% for Nike.

    Button
  • Slide title

    Customers also increasingly like the quality of Reebok’s products. Customer sentiment toward Quality surged 8% for Reebok in the last three months, while it fell slightly for competitors, including Nike (-1%).

    Button
  • Slide title

    Customer sentiment toward Brand Image fell for most of the major athletic footwear companies except for Reebok, which was actually +3%. It fell most for Nike (-4%) and Adidas (-4%). Many people have left negative comments on Nike’s social stances.

    Button
  • Slide title

    Write your caption here
    Button

Please contact our team for a deeper look at HundredX's Fashion, Apparel, and Footwear data, which includes more than 600,000 pieces of customer feedback across 230 apparel brands.


  1. All metrics presented, including Net Consumption (Consumption Intent) and Net Positive Percent / Sentiment are presented on a trailing three-month basis unless otherwise noted.
  2. Purchase Intent for fashion, apparel, and footwear represents the percentage of customers who expect to spend more of that brand over the next 12 months, minus those that intend to spend less.
  3. HundredX measures sentiment towards a driver of customer satisfaction as Net Positive Percent (NPP), which is the percentage of customers who view a factor as a positive (reason they liked the products, people, or experiences) minus the percentage who see the same factor as a negative.

Strategy Made Smarter


HundredX works with a variety of companies and their investors to answer some of the most important strategy questions in business:

  • Where are customers "migrating"?
  • What are they saying they will use more of in the next 12 months?
  • What are the key drivers of their purchase decisions and financial outcomes?


Current clients see immediate benefits across multiple areas including strategy, finance, operations, pricing, investing, and marketing.


Our insights enable business leaders to define and identify specific drivers and decisions enabling them to grow their market share.


Please contact our team to learn more about which businesses across 75 industries are best positioned with customers and the decisions you can make to grow your brand’s market share.

####


HundredX is a mission-based data and insights provider. HundredX does not make investment recommendations. However, we believe in the wisdom of the crowd to inform the outlook for businesses and industries. For more info on specific drivers of customer satisfaction, other companies within 75+ other industries we cover, or if you'd like to learn more about using Data for Good, please reach out: https://hundredx.com/contact.

Share This Article

06 May, 2024
Sure, lattes, mochaccinos, and cappuccinos are pricey, but they taste delicious. For many consumers, the great taste of coffee shop coffee made it worth the cost. But customers at Starbucks aren't so sure the tradeoff is worth it anymore. Examining more than 420,000 pieces of feedback across the Quick, Fast, Casual (QFC) industry, including over 21,000 on Starbucks, we find: Starbuck's Purchase Intent 1,2 is down 3% over the past six months, with most of that dip occurring over the past few months. By contrast, Dunkin' Donuts has remained within a tight range over the past six months, as did an average of other, smaller coffee chains. Customers increasingly see less value in Starbucks. Starbuck's Value perception 3 fell 5% over the past six months, compared to just 1% for Dunkin' Donuts. However, it also fell 5% for the average of the smaller coffee chains. Coffee drinkers feel significantly unhappier about Starbuck's quality and taste. Starbuck's Taste perception fell 4% over the past six months, while rising 1% for competitors. Likewise, its Quality perception dipped 3% over the same time period (and 8% over the year). Ultimately, Starbuck's perceived drop in taste is leading inflation-weary consumers to say they plan to spend less at the coffee chain, as the value just isn't as good.
06 May, 2024
Forbes Best Brands for Social Impact, Powered by HundredX
06 May, 2024
Ozempic once dominated the headlines, but GLP-1 competitor Mounjaro is winning over customers. GLP-1 drugs, used for treating diabetes and aiding in weight loss, are relatively new on the market yet have surged in popularity over the last year. They're becoming so popular that J.P. Morgan estimates that 30 million people in the US may be using a GLP-1 drug by 2030. This statistic presents a significant potential for early drug creator Novo Nordisk (Ozempic, Wegovy), and perhaps an even bigger one for Eli Lilly (Mounjaro, Zepbound). HundredX data indicates Eli Lilly is in a position to win over Novo Nordisk as Mounjaro's Usage Intent widens against the competition. Ozempic may have name recognition, but customers feel more positively about Mounjaro's effectiveness and lifestyle impact, even if they aren't excited about its high price. Examining 1,500 pieces of customer feedback across Mounjaro, Ozempic, and Wegovy, we find: GLP-1 users increasingly say they plan to use Mounjaro more, and Ozempic less . Mounjaro’s Usage Intent is up 19% since July, Wegovy’s is up 3%, and Ozempic has stayed within a tight range. Customers feel Mounjaro is more effective than competing drugs, but it’s harder to get . Mounjaro outperforms other GLP-1 drugs in effectiveness, lifestyle impact, and side effects. However, customers dislike its cost and availably more than competitors.
Share by: